For women with a rare subtype of epithelial ovarian or peritoneum cancer, known as low-grade serous carcinoma (LGSC), hormone maintenance therapy (HMT) may significantly improve survival, according to a new study from researchers ...
Feb 21, 2017
0
0
(HealthDay)—For men with testicular cancer undergoing retroperitoneal lymph node dissection (RPLND), alvimopan may reduce hospital length of stay (LOS) and enhance gastrointestinal recovery, according to a study presented ...
Feb 17, 2017
0
0
(HealthDay)—Losing weight is associated with a significantly lower risk of endometrial cancer, and that benefit appears to be greatest in obese women, according to a study published online Feb. 6 in the Journal of Clinical ...
Feb 7, 2017
0
0
A large-scale, population based study led by Dr. Laurent Azoulay, Senior Investigator with the Lady Davis Institute at the Jewish General Hospital, has concluded that the use of androgen deprivation therapy (ADT) to treat ...
Jan 26, 2017
0
2
(HealthDay)—Younger survivors of thyroid cancer are at increased risk for certain types of health problems later in life, according to a study presented at the American Society of Clinical Oncology's Cancer Survivorship ...
Jan 26, 2017
0
2
(HealthDay)—Breast cancer can take a heavy toll on the partners of patients, too, according to a study presented at the American Society of Clinical Oncology's Cancer Survivorship Symposium, held from Jan. 27 to 28 in San ...
Jan 25, 2017
0
0
(HealthDay)—Exercise can help cancer patients cope with their treatment, but as many as 75 percent reduce their physical activity after diagnosis, according to a study presented at the American Society of Clinical Oncology's ...
Jan 25, 2017
0
0
(HealthDay)—In a clinical practice guideline published online Jan. 16 in the Journal of Clinical Oncology, recommendations are presented for the management of patients with small renal masses (SRMs).
Jan 19, 2017
0
0
(HealthDay)—For women with breast cancer, experiencing a worsening in menopause-specific quality of life (QoL) is associated with early treatment discontinuation, according to a study published online Jan. 9 in the Journal ...
Jan 12, 2017
0
1
(HealthDay)—For patients with advanced unresectable hepatocellular carcinoma, the effect of sorafenib on overall survival (OS) is dependent on patients' hepatitis status, according to a meta-analysis published online Jan. ...
Jan 9, 2017
0
0
